首页> 外文期刊>Japanese journal of clinical oncology. >EGFR mutation of adenocarcinoma in congenital cystic adenomatoid malformation/congenital pulmonary airway malformation: a case report.
【24h】

EGFR mutation of adenocarcinoma in congenital cystic adenomatoid malformation/congenital pulmonary airway malformation: a case report.

机译:先天性囊性腺瘤样畸形/先天性肺气道畸形中腺癌的EGFR突变:1例。

获取原文
获取原文并翻译 | 示例
           

摘要

An 80-year-old man underwent right upper lobectomy for the resection of multiple cysts accompanied by a nodule. The pathological diagnosis was adenocarcinoma with surrounding atypical epithelial cell proliferation in a Type 1 congenital cystic adenomatoid malformation/congenital pulmonary airway malformation. There was epidermal growth factor receptor mutation in the adenocarcinoma and surrounding atypical epithelial cells that had proliferated. Malignant transformation of congenital cystic adenomatoid malformation/congenital pulmonary airway malformation may be related to the epidermal growth factor receptor pathway in this case, with atypical epithelial cell proliferation as a precursor. We emphasize the importance of complete resection of congenital cystic adenomatoid malformation/congenital pulmonary airway malformation and the possibility of treatment with epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor-mutated cases.
机译:一名80岁的男子接受了右上叶切除术,以切除伴有结节的多个囊肿。病理诊断为腺癌,伴有1型先天性囊性腺瘤样畸形/先天性肺气道畸形周围非典型上皮细胞增生。在已经扩散的腺癌和周围的非典型上皮细胞中存在表皮生长因子受体突变。在这种情况下,以非典型上皮细胞增殖为先兆,先天性囊性腺瘤样畸形/先天性肺气道畸形的恶变可能与表皮生长因子受体途径有关。我们强调完全切除先天性囊性腺瘤样畸形/先天性肺气道畸形的重要性,以及在表皮生长因子受体突变的病例中使用表皮生长因子受体酪氨酸激酶抑制剂治疗的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号